Morgan Stanley Discount Zert MET .../ DE000ME7Y1P2 /
30.05.2024 8:59:26 | Изменение-0.15 | Бид9:28:53 | Предложение9:28:53 | Базовый актив | Цена исполнения | Дата истечения | Тип опциона |
---|---|---|---|---|---|---|---|
45.19EUR | -0.33% | 45.17 Величина цены спроса: 75 |
45.95 Величина цены предложения: 75 |
MetLife Inc | - USD | 27.09.2024 | Call |
GlobeNewswire
9:42
Bayer and Burning Rock collaborate to increase patient access to precision cancer medicines
GlobeNewswire
9:01
Persistent Systems Selects Zscaler to Launch Technology Modernization and Renewable Energy Initiativ...
GlobeNewswire
9:00
Curium Announces First Commercial Doses in France of Pylclari® – an Innovative 18F-Psma Pet Tracer I...
GlobeNewswire
9:00
Green Bioactives Reports Remarkable Cognitive Benefits of its Newly Launched Memory-boosting Nutrace...
GlobeNewswire
8:35
Nxera Pharma to Receive $4.6 Million in Milestone Payments from Centessa Pharmaceuticals
GlobeNewswire
8:30
Samsung Bioepis to Present Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimi...
GlobeNewswire
8:30
BlueRock Therapeutics receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’...
GlobeNewswire
8:30
Nxera Pharma and PrecisionLife Expand Strategic R&D Partnership into New Therapeutic Area
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница